Editorial: Oncolytic virotherapy
Front Mol Biosci
.
2023 Nov 1:10:1287885.
doi: 10.3389/fmolb.2023.1287885.
eCollection 2023.
Authors
Ahmed Majeed Al-Shammari
1
,
Pier Paolo Piccaluga
2
3
Affiliations
1
Experimental Therapy Department, Iraqi Center for Cancer and Medical Genetic Research, Mustansiriyah University, Baghdad, Iraq.
2
Biobank of Research, IRCCS Azienda Opedaliera-Universitaria di Bologna, Bologna, Italy.
3
Department of Medical and Surgical Sciences, Bologna University School of Medicine, Bologna, Italy.
PMID:
38028532
PMCID:
PMC10646606
DOI:
10.3389/fmolb.2023.1287885
No abstract available
Keywords:
T-VEC; combination therapies; hsv; immuno-virotherapy; newcastle disease virus (NDV).
Publication types
Editorial